{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T01:21:00Z","timestamp":1788916860323,"version":"build-2803163510"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2017,8,3]],"date-time":"2017-08-03T00:00:00Z","timestamp":1501718400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>BACKGROUND<\/jats:title>\n                  <jats:p>We investigated the efficacy and mechanisms of tadalafil, a selective phosphodiesterase 5 inhibitor, in treating preeclampsia (PE) with fetal growth restriction (FGR) using L-NG-nitroarginine methyl ester (L-NAME)-induced PE with FGR in pregnant mice as our experimental model.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>C57BL\/6 mice were divided into 2 groups 11 days postcoitum (d.p.c.). A control group of dams (C dam) received 0.5% carboxymethylcellulose (CMC). A L-NAME-treated group received 1 mg\/ml L-NAME dissolved in CMC. The L-NAME-treated dams were divided into 2 subgroups 13 d.p.c. One subgroup continued to receive L-NAME (L dams). The other subgroup received L-NAME with 0.08 mg\/ml tadalafil suspended in CMC (TL dams). Maternal systolic blood pressure (SBP) and proteinuria were assessed 16 d.p.c. Fetal weight was recorded, and placentas and maternal kidneys were collected 17 d.p.c.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Maternal SBP, proteinuria, and fetal weight were improved for TL dams compared to L dams. The placental concentration of placental growth factor (PlGF) was higher for TL dams than for the C and L dams. The placental maternal blood sinuses of L dams were narrower than those of C dams, but those of TL dams improved to a similar width as C dams. Glomerular oxidative stress was ameliorated in TL dams compared to L dams.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Tadalafil dilates the placental maternal blood sinuses, which leads to increase PlGF production, and contributes to facilitate fetal growth and improve maternal SBP. Moreover, tadalafil ameliorates glomerular damage by reducing oxidative stress. These results suggest that tadalafil is a candidate for treatment of PE with FGR.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ajh\/hpx130","type":"journal-article","created":{"date-parts":[[2017,7,11]],"date-time":"2017-07-11T19:18:23Z","timestamp":1499800703000},"page":"89-96","source":"Crossref","is-referenced-by-count":41,"title":["Tadalafil Improves L-NG-Nitroarginine Methyl Ester-Induced Preeclampsia With Fetal Growth Restriction-Like Symptoms in Pregnant Mice"],"prefix":"10.1093","volume":"31","author":[{"given":"Kento","family":"Yoshikawa","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Mie University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Umekawa","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Mie University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Maki","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Mie University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiko","family":"Kubo","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Mie University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Nii","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Mie University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayo","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Mie University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Mie University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Osato","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Mie University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Kamimoto","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Mie University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Mie University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ikemura","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Mie University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Okuda","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Mie University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kan","family":"Katayama","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Nephrology, Cardiology and Nephrology, Mie University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takekazu","family":"Miyoshi","sequence":"additional","affiliation":[{"name":"Department of Perinatology and Gynecology, National Cerebral and Cardiovascular Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Hosoda","sequence":"additional","affiliation":[{"name":"Department of Regenerative Medicine and Tissue Engineering, National Cerebral and Cardiovascular Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Ma","sequence":"additional","affiliation":[{"name":"Faculty of Health Science, Suzuka University of Medical Science, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshimichi","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Pathology and Matrix Biology, Pathology and Matrix Biology, Mie University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Mie University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,8,3]]},"reference":[{"key":"2022111809292434500_CIT0001","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ajog.2016.03.001","article-title":"Placental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human Development","volume":"215","author":"Ilekis","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"2022111809292434500_CIT0002","doi-asserted-by":"crossref","first-page":"R81","DOI":"10.1530\/JOE-17-0185","article-title":"Treating the dysfunctional placenta","volume":"234","author":"Sibley","year":"2017","journal-title":"J Endocrinol"},{"key":"2022111809292434500_CIT0003","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.placenta.2011.06.025","article-title":"Role of nitric oxide in placental vascular development and function","volume":"32","author":"Krause","year":"2011","journal-title":"Placenta"},{"key":"2022111809292434500_CIT0004","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrd893","article-title":"Phosphodiesterase 5 inhibitors: current status and potential applications","volume":"1","author":"Rotella","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"2022111809292434500_CIT0005","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/AOG.0000000000001518","article-title":"Perinatal and hemodynamic evaluation of sildenafil citrate for preeclampsia treatment: a randomized controlled trial","volume":"128","author":"Trapani","year":"2016","journal-title":"Obstet Gynecol"},{"key":"2022111809292434500_CIT0006","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/s13256-016-1098-x","article-title":"Early-onset fetal growth restriction treated with the long-acting phosphodiesterase-5 inhibitor tadalafil: a case report","volume":"10","author":"Sakamoto","year":"2016","journal-title":"J Med Case Rep"},{"key":"2022111809292434500_CIT0007","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/jog.13218","article-title":"Retrospective study of tadalafil for fetal growth restriction: Impact on maternal and perinatal outcomes","volume":"43","author":"Kubo","year":"2017","journal-title":"J Obstet Gynaecol Res"},{"key":"2022111809292434500_CIT0008","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/jog.13335","article-title":"Treatment using tadalafil for severe pre-eclampsia with fetal growth restriction","volume":"43","author":"Tanaka","year":"2017","journal-title":"J Obstet Gynaecol Res"},{"key":"2022111809292434500_CIT0009","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/jog.13345","article-title":"Safety and dose-finding trial of tadalafil administrated for fetal growth restriction; A phase 1 clinical study","volume":"43","author":"Kubo","year":"2017","journal-title":"J Obstet Gynaecol Res"},{"key":"2022111809292434500_CIT0010","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jss.2013.08.005","article-title":"Neuroprotective effect of tadalafil, a PDE-5 inhibitor, and its modulation by L-NAME in mouse model of ischemia-reperfusion injury","volume":"186","author":"Gulati","year":"2014","journal-title":"J Surg Res"},{"key":"2022111809292434500_CIT0011","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/FTD.0000000000000055","article-title":"Plasma concentrations of tadalafil in children with pulmonary arterial hypertension","volume":"36","author":"Kohno","year":"2014","journal-title":"Ther Drug Monit"},{"key":"2022111809292434500_CIT0012","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1016\/j.jchromb.2010.07.022","article-title":"A simple and sensitive HPLC fluorescence method for determination of tadalafil in mouse plasma","volume":"878","author":"Farthing","year":"2010","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"2022111809292434500_CIT0013","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.neuropharm.2012.06.052","article-title":"Tadalafil crosses the blood-brain barrier and reverses cognitive dysfunction in a mouse model of AD","volume":"64","author":"Garc\u00eda-Barroso","year":"2013","journal-title":"Neuropharmacology"},{"key":"2022111809292434500_CIT0014","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1007\/s00125-010-1784-y","article-title":"Transgenic mice overproducing human thioredoxin-1, an antioxidative and anti-apoptotic protein, prevents diabetic embryopathy","volume":"53","author":"Kamimoto","year":"2010","journal-title":"Diabetologia"},{"key":"2022111809292434500_CIT0015","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/0002-9378(92)91863-6","article-title":"Attenuation of the vasoconstrictor effects of thromboxane and endothelin by nitric oxide in the human fetal-placental circulation","volume":"166","author":"Myatt","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"2022111809292434500_CIT0016","article-title":"New models of pregnancy-associated hypertension","author":"Cushen","year":"","journal-title":"Am J Hypertens"},{"key":"2022111809292434500_CIT0017","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1111\/j.1471-0528.2012.03430.x","article-title":"Sildenafil citrate improves perinatal outcome in fetuses from pre-eclamptic rats","volume":"119","author":"Herraiz","year":"2012","journal-title":"BJOG"},{"key":"2022111809292434500_CIT0018","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejogrb.2009.11.005","article-title":"Sildenafil citrate improves fetal outcomes in pregnant, L-NAME treated, Sprague-Dawley rats","volume":"149","author":"Ramesar","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2022111809292434500_CIT0019","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejogrb.2014.08.021","article-title":"The optimization of a chronic nitric oxide synthase (NOS) inhibition model of pre-eclampsia by evaluating physiological changes","volume":"182","author":"Baijnath","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2022111809292434500_CIT0020","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1055\/s-0032-1304823","article-title":"Effects of sildenafil in N\u03c9-nitro-L-arginine methyl ester-induced intrauterine growth restriction in a rat model","volume":"29","author":"Nassar","year":"2012","journal-title":"Am J Perinatol"},{"key":"2022111809292434500_CIT0021","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0303-7207(01)00703-1","article-title":"Trophoblast functions, angiogenesis and remodeling of the maternal vasculature in the placenta","volume":"187","author":"Cross","year":"2002","journal-title":"Mol Cell Endocrinol"},{"key":"2022111809292434500_CIT0022","first-page":"180","article-title":"Development of structures and transport functions in the mouse placenta","volume":"20","author":"Watson","year":"2005","journal-title":"Physiol Bethesda Md"},{"key":"2022111809292434500_CIT0023"},{"key":"2022111809292434500_CIT0024","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1172\/JCI83918","article-title":"Soluble fms-like tyrosine kinase 1 promotes angiotensin II sensitivity in preeclampsia","volume":"126","author":"Burke","year":"2016","journal-title":"J Clin Invest"},{"key":"2022111809292434500_CIT0025"},{"key":"2022111809292434500_CIT0026","first-page":"151","article-title":"Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: molecular evidence for \u201cplacental hyperoxia\u201d in intrauterine growth restriction","volume":"79","author":"Khaliq","year":"1999","journal-title":"Lab Invest"},{"key":"2022111809292434500_CIT0027","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/humrep\/den114","article-title":"Hypoxia is responsible for soluble vascular endothelial growth factor receptor-1 (VEGFR-1) but not for soluble endoglin induction in villous trophoblast","volume":"23","author":"Munaut","year":"2008","journal-title":"Hum Reprod"},{"key":"2022111809292434500_CIT0028","doi-asserted-by":"crossref","first-page":"H1381","DOI":"10.1152\/ajpheart.00922.2007","article-title":"Placental growth factor is a potent vasodilator of rat and human resistance arteries","volume":"294","author":"Osol","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2022111809292434500_CIT0029","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1210\/jc.2007-1550","article-title":"Placental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnancies","volume":"93","author":"Gu","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2022111809292434500_CIT0030","doi-asserted-by":"crossref","DOI":"10.1161\/HYPERTENSIONAHA.117.09466","article-title":"Mechanisms and treatment of halogen inhalation-induced pulmonary and systemic injuries in pregnant mice","author":"Lambert","year":"2017","journal-title":"Hypertension"},{"key":"2022111809292434500_CIT0031","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1084\/jem.20080398","article-title":"Elevated levels of placental growth factor represent an adaptive host response in sepsis","volume":"205","author":"Yano","year":"2008","journal-title":"J Exp Med"},{"key":"2022111809292434500_CIT0032","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1113\/JP273393","article-title":"Sildenafil therapy for fetal cardiovascular dysfunction during hypoxic development: studies in the chick embryo","volume":"595","author":"Itani","year":"2017","journal-title":"J Physiol"},{"key":"2022111809292434500_CIT0033","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1161\/01.HYP.32.6.958","article-title":"Chronic nitric oxide inhibition model six years on","volume":"32","author":"Zatz","year":"1998","journal-title":"Hypertension"},{"key":"2022111809292434500_CIT0034","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11010-016-2897-5","article-title":"The effects of sildenafil citrate on urinary podocin and nephrin mRNA expression in an L-NAME model of pre-eclampsia","volume":"427","author":"Baijnath","year":"2017","journal-title":"Mol Cell Biochem"},{"key":"2022111809292434500_CIT0035","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nrneph.2014.102","article-title":"Pre-eclampsia part 1: current understanding of its pathophysiology","volume":"10","author":"Chaiworapongsa","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"2022111809292434500_CIT0036","doi-asserted-by":"crossref","first-page":"F1404","DOI":"10.1152\/ajprenal.00260.2006","article-title":"Vitamin E reduces glomerulosclerosis, restores renal neuronal NOS, and suppresses oxidative stress in the 5\/6 nephrectomized rat","volume":"292","author":"Tain","year":"2007","journal-title":"Am J Physiol Renal Physiol"}],"container-title":["American Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajh\/article-pdf\/31\/1\/89\/47108079\/ajh_31_1_89.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajh\/article-pdf\/31\/1\/89\/47108079\/ajh_31_1_89.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T09:30:17Z","timestamp":1668763817000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajh\/article\/31\/1\/89\/4061455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,3]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,8,3]]},"published-print":{"date-parts":[[2018,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ajh\/hpx130","relation":{},"ISSN":["0895-7061","1941-7225"],"issn-type":[{"value":"0895-7061","type":"print"},{"value":"1941-7225","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,1]]},"published":{"date-parts":[[2017,8,3]]}}}